EUVIMEDEUVIMED entdecken
Systematische Übersicht

Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology

A Gonzalez-Cantero iD, W H Boehncke, J De Sutter, J L Zamorano, J Lambert, L Puig iD

Journal of the European Academy of Dermatology and Venereology · 2023-09 · 37 (9) · 1697-1705

DOI: 10.1111/jdv.19191 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023-06. Verfasst von A Gonzalez-Cantero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitario Ramón y Cajal, Madrid, Spain. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dermatology, Psoriasis, Cardiovascular Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is associated with an increased mortality risk, with cardiovascular disease being the leading excess cause (in a dose–response manner with psoriasis severity). Statins have demonstrated a reduction in all‐cause mortality with no excess of adverse events among the general population. The underuse of interventions in cardiovascular prevention, such as statins, for patients with psoriasis may be the result of an insufficient evaluation.

Objectives

To provide the dermatologist with a tool for systematizing the treatment of dyslipidemia in psoriasis, which generally escapes the scope of dermatological practice, and to facilitate decision‐making about the referral and treatment of patients.

Methods

The Psoriasis Task Force of the European Academy of Dermatology and Venereology performed this two‐phase study to achieve a consensus and create recommendations on the use of statin therapy in patients with psoriasis. The first phase included a systematic review to identify a list of outline concepts and recommendations according to guidelines. The second phase consisted in a two‐round Delphi study to evaluate those recommendations not literally taken from guidelines.

Results

A list of 47 concepts and recommendations to be followed by dermatologists involved in the treatment of patients with moderate–severe psoriasis was created. It included six main concepts about cardiovascular risk and psoriasis, six items related with the role of low‐density lipoprotein cholesterol (LDL‐c) and the benefits of statin treatment in psoriasis patients, eight recommendations about how cardiovascular risk should be assessed, three on the role of non‐invasive cardiovascular imaging, three on LDL‐c thresholds, eight key points related to statin prescription, 10 on statin treatment follow‐up and three on patient referral to another specialist.

Conclusions

The application of this position statement (close final list of concepts and recommendations) will help dermatologists to manage dyslipidemia and help psoriasis patients to reduce their cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDermatologyPsoriasisCardiovascular DiseasesDyslipidemiasHumansCholesterol, LDL

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDL

Autor:innen und Institutionen

  • Department of Dermatology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
  • Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Cardiology, AZ Maria Middelares, Ghent, Belgium.
  • Departamento de Cardiología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

ORCID-Profile: A Gonzalez-Cantero, L Puig

Zitieren

APA

Gonzalez-Cantero, A., Boehncke, W. H., De Sutter, J., Zamorano, J. L., Lambert, J., & Puig, L. (2023). Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology. Journal of the European Academy of Dermatology and Venereology, 37(9), 1697-1705. https://doi.org/10.1111/jdv.19191

Vancouver

Gonzalez-Cantero A, Boehncke WH, De Sutter J, Zamorano JL, Lambert J, Puig L. Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology. Journal of the European Academy of Dermatology and Venereology. 2023;37(9):1697-1705. doi:10.1111/jdv.19191

BibTeX
@article{GonzalezCantero2023,
  author = {Gonzalez-Cantero, A and Boehncke, W H and De Sutter, J and Zamorano, J L and Lambert, J and Puig, L},
  title = {Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {9},
  pages = {1697--1705},
  doi = {10.1111/jdv.19191}
}
Kostenlos starten →